Astria Therapeutics, Inc. (ATXS) Net Income by Year
Astria Therapeutics, Inc. reported a net loss of $94.3M in fiscal year 2024. This represents a decrease of 29.3% from the prior fiscal year. The table below carries 12 fiscal years, from 2013 to 2024, and the quarters Astria Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ATXS Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
ATXS Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Astria Therapeutics, Inc. financials
Frequently Asked Questions
What was Astria Therapeutics, Inc.'s net income in fiscal year 2024?
Astria Therapeutics, Inc. reported a net loss of $94.3M in fiscal year 2024.
How fast is Astria Therapeutics, Inc.'s net income growing?
Astria Therapeutics, Inc. (ATXS) net income fell by 29.3% year over year, from -$72.9M to -$94.3M in fiscal year 2024.
How has Astria Therapeutics, Inc.'s net income changed over the years?
Across the 12 fiscal years this page covers, Astria Therapeutics, Inc. (ATXS) net income went from -$18.1M in fiscal year 2013 to -$94.3M in fiscal year 2024.
What was Astria Therapeutics, Inc.'s net income in the most recent quarter?
Astria Therapeutics, Inc. (ATXS) reported -$31.6M in net income in Q3 2025. This represents a decrease of 29.0% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Astria Therapeutics, Inc. (ATXS) reported on that line in every period on record.